Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hoff

Showing results (361-370 of 514) with videos related to

Pageof 52
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 3, 2017
Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, NorwayM Hoff, H E Meyer, S Skurtveit, et al.
Transfusion|March 10, 2010
Immune-mediated pancytopenia induced by oxaliplatin: a case reportRita Fontão-Wendel, Paulo M Hoff, Arlette Lazar, et al.
Breast Cancer (Tokyo, Japan)|September 20, 2014
Feasibility of two schedules of weekly paclitaxel in HER2-negative early breast cancer in a Brazilian community settingIuri A Santana, Julia Andrade Oliveira, Julianne Maria da Silva Lima, et al.
British Journal of Cancer|October 24, 2013
Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapyS K M Spencer, A J C Pommier, S R Morgan, et al.
Case Reports in Oncology|October 11, 2016
Response to Paclitaxel in an Adult Patient with Advanced Kaposiform HemangioendotheliomaJosé Maurício Mota, Mariana Scaranti, Leonardo G Fonseca, et al.
International Journal of Gastrointestinal Cancer|March 13, 2003
Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabineEverardo D Saad, Marcel C Machado, Dalia Wajsbrot, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2013
KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranibJohn C Smith, Laura Brooks, Paulo M Hoff, et al.
Journal of the Air & Waste Management Association (1995)|May 29, 1998
Inter-laboratory comparison of air particulate monitoring dataZ Nejedlý, J L Campbell, W J Teesdale, et al.
Clinical Colorectal Cancer|August 13, 2016
Safety and Efficacy of a Modified FLOX Adjuvant Regimen for Patients With Stage III Colorectal Cancer Treated in the CommunityBruno Mendonça Protásio, Adriana Matutino, Liana Valente Lage, et al.
Molecular Psychiatry|December 19, 1998
Evidence for a chromosome 2p13-14 schizophrenia susceptibility locus in families from Palau, MicronesiaH Coon, M Myles-Worsley, J Tiobech, et al.
Pageof 52

Showing results (361-370 of 514) with videos related to

Sort By:
Pageof 52
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 3, 2017
Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, NorwayM Hoff, H E Meyer, S Skurtveit, et al.
Transfusion|March 10, 2010
Immune-mediated pancytopenia induced by oxaliplatin: a case reportRita Fontão-Wendel, Paulo M Hoff, Arlette Lazar, et al.
Breast Cancer (Tokyo, Japan)|September 20, 2014
Feasibility of two schedules of weekly paclitaxel in HER2-negative early breast cancer in a Brazilian community settingIuri A Santana, Julia Andrade Oliveira, Julianne Maria da Silva Lima, et al.
British Journal of Cancer|October 24, 2013
Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapyS K M Spencer, A J C Pommier, S R Morgan, et al.
Case Reports in Oncology|October 11, 2016
Response to Paclitaxel in an Adult Patient with Advanced Kaposiform HemangioendotheliomaJosé Maurício Mota, Mariana Scaranti, Leonardo G Fonseca, et al.
International Journal of Gastrointestinal Cancer|March 13, 2003
Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabineEverardo D Saad, Marcel C Machado, Dalia Wajsbrot, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2013
KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranibJohn C Smith, Laura Brooks, Paulo M Hoff, et al.
Journal of the Air & Waste Management Association (1995)|May 29, 1998
Inter-laboratory comparison of air particulate monitoring dataZ Nejedlý, J L Campbell, W J Teesdale, et al.
Clinical Colorectal Cancer|August 13, 2016
Safety and Efficacy of a Modified FLOX Adjuvant Regimen for Patients With Stage III Colorectal Cancer Treated in the CommunityBruno Mendonça Protásio, Adriana Matutino, Liana Valente Lage, et al.
Molecular Psychiatry|December 19, 1998
Evidence for a chromosome 2p13-14 schizophrenia susceptibility locus in families from Palau, MicronesiaH Coon, M Myles-Worsley, J Tiobech, et al.
Pageof 52